



Our Mission is to enable the restoration of skin health. We do this through high-quality precision sampling and advanced molecular testing to objectively assess health-status and guide therapeutic and care decisions.
We are focused on improving outcomes and delivering high quality value-based medicine.
We leverage decades of experience in genomics, biotechnology, and skin biology to deliver advanced molecular diagnostics that inform critical therapeutic decisions.
From Research to Medicine we leverage long-standing academic and commercial relationships to facilitate market access, regulatory compliance, and operational scalability.
The foundation of precision medicine is the quality of the tissue sample. By combining our advanced, minimally invasive sampling technology with precise molecular testing, Diapeutic Dx eliminates the ambiguity of traditional diagnostics. This synergy delivers profound benefits across the healthcare spectrum.
Better Care Decisions: Accurate molecular data enables highly personalized therapies. Patients avoid painful traditional biopsies and receive treatments explicitly tailored to their unique pathology, improving outcomes.
Clinical Objectivity: High-yield samples provide indisputable molecular documentation, removing visual guesswork. Furthermore, our devices facilitate highly reimbursable, efficient in-office procedures.
Paying for What Works: Definitive molecular diagnostics prevent wasteful spending on trial-and-error treatments. Payers achieve superior health-economic value by funding targeted, data-backed interventions.
Subjective diagnosis leads to trial-and-error medicine. Molecular tests offer objective assessment and therapeutic decision making which improves outcomes and lowers costs.
Projected 2024 TAM
Source: Grand View Research, 2024Projected 2024 TAM
Source: Zion Market Research, 2024Projected 2024 TAM
Source: Custom Market Insights, 2024